ConductScience.org, home

Paper17519955

Heparanase in glomerular diseases.

van den Hoven MJ and 5 others. Kidney Int, 2007. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. Heparanase in glomerular diseases. Papers, record 17519955. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519955

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heparanase in glomerular diseases.
PubMed
Journal
Kidney Int
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van den Hoven MJM J
2Rops ALA L
3Vlodavsky II
4Levidiotis VV
5Berden JHJ H
6van der Vlag JJ

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucuronidaseMajor topic
ProteinuriaMajor topic
Heparan Sulfate
Humans
Kidney Glomerulus
Heparanase

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
41497483Identification and Verification of Biomarkers Related to Polyamine Metabolism in Diabetic Nephropathy.J Diabetes Res2025https://conductscience.org/library/papers/41497483PubMed
41272309The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease.Nat Rev Nephrol2026https://conductscience.org/library/papers/41272309PubMed
40860946Identification of Neutrophil Extracellular Trap-Related Biomarkers in Diabetic Foot Ulcers Based on Bioinformatics.J Inflamm Res2025https://conductscience.org/library/papers/40860946PubMed
40495439Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside.J Cell Physiol2025https://conductscience.org/library/papers/40495439PubMed
40453077Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy.Front Immunol2025https://conductscience.org/library/papers/40453077PubMed
39474588Complement, Coagulation, and Fibrinolysis: The Role of the Endothelium and Its Glycocalyx Layer in Xenotransplantation.Transpl Int2024https://conductscience.org/library/papers/39474588PubMed
37456170Role of heparanase in sepsis‑related acute kidney injury (Review).Exp Ther Med2023https://conductscience.org/library/papers/37456170PubMed
37273258Early diabetic kidney disease: Focus on the glycocalyx.World J Diabetes2023https://conductscience.org/library/papers/37273258PubMed
37180718Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy.Front Pharmacol2023https://conductscience.org/library/papers/37180718PubMed
35336857Increased Heparanase Levels in Urine during Acute Puumala Orthohantavirus Infection Are Associated with Disease Severity.Viruses2022https://conductscience.org/library/papers/35336857PubMed
34857011Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34857011PubMed
34681753The Heparanase Regulatory Network in Health and Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34681753PubMed
33794549Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.Semin Thromb Hemost2021https://conductscience.org/library/papers/33794549PubMed
33539214Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection.Clin Appl Thromb Hemost2021https://conductscience.org/library/papers/33539214PubMed
32274732Heparanase in Acute Kidney Injury.Adv Exp Med Biol2020https://conductscience.org/library/papers/32274732PubMed
32274705Forty Years of Basic and Translational Heparanase Research.Adv Exp Med Biol2020https://conductscience.org/library/papers/32274705PubMed
31103854Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.iScience2019https://conductscience.org/library/papers/31103854PubMed
30858582Glycosylation in health and disease.Nat Rev Nephrol2019https://conductscience.org/library/papers/30858582PubMed
30319431Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression.Front Physiol2018https://conductscience.org/library/papers/30319431PubMed
29988342Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.Front Immunol2018https://conductscience.org/library/papers/29988342PubMed

See all 58 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
HPSE10855PubTator's text mininghttps://conductscience.org/library/genes/10855NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519955

GET https://conductscience.org/api/papers/v1/17519955/cited_by?page=2